Resolution of the online meeting of Russian experts on the EMPEROR-REDUCED trial

Resolution of the online meeting of Russian experts on the EMPEROR-REDUCED trial

At the online meeting held on September 3, 2020, the results of the international multicenter trial EMPEROR-REDUCED were considered. Number of proposals and recommendations for the further study of cardiovascular and renal effects of empagliflozin and its practical use in heart failure patients were...

Full description

Bibliographic Details
Main Authors: G. P. Arutyunov, A. G. Arutyunov, E. I. Tarlovskaya, A. S. Ametov, N. G. Vinogradova, A. A. Garganeeva, M. G. Glezer, I. V. Zhirov, M. V. Ilyin, N. A. Koziolova, A. O. Konradi, A. Yu. Lebedeva, Yu. M. Lopatin, S. V. Nedogoda, V. V. Salukhov, M. Yu. Sitnikova, S. N. Tereshchenko, S. N. Tolstov, Yu. Sh. Khalimov, N. R. Khasanov, A. I. Chesnikova, V. Giga, M. Paсker
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2020-12-01
Series:Российский кардиологический журнал
Subjects:
empagliflozin
heart failure
cardiovascular mortality
chronic kidney disease
emperor-reduced trial
Online Access:https://russjcardiol.elpub.ru/jour/article/view/4167

Internet

https://russjcardiol.elpub.ru/jour/article/view/4167

Similar Items